sulfadiazine

Sulfadiazine (Sulphadiazine) is a synthetic pyrimidinyl sulfonamide derivative, short-acting bacteriostatic Sulfadiazine inhibits bacterial folic acid synthesis by competing with para-aminobenzoic acid. It is used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.

Sulfadiazine sodium (Sulfadiazin-natrium) is a sodium salt form of sulfadiazine, an intermediate-acting bacteriostatic, synthetic sulfanilamide derivative.

Sulfadiazine-D4 is a deuterium labeled Sulfadiazine. Sulfadiazine (T0930) used for the treatment of toxoplasmosis.

Silver sulfadiazine (Dermazin) is a sulfonamide-based topical agent with antibacterial and antifungal activity.

Sulfadiazine (Standard) is the standard substance of Sulfadiazine, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Sulfadiazine (Sulphadiazine) is a synthetic pyrimidinyl sulfonamide derivative, short-acting bacteriostatic Sulfadiazine inhibits bacterial folic acid synthesis by competing with para-aminobenzoic acid. It is used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.

Sulfadiazine-BSA is a hapten-carrier protein conjugate formed by coupling Sulfadiazine to bovine serum albumin (BSA). As a hapten, Sulfadiazine alone cannot induce an immune response and must be conjugated to a large molecular protein to become a complete antigen with immunogenicity. Sulfadiazine-BSA may be supplied as a lyophilized powder or as a solution. The solution is prepared in 0.01 M PBS (pH 7.4) buffer at a typical concentration of 1 mg/mL.

Sulfameter (Sulfametoxydiazine) is a long-acting sulfonamide antibacterial agent used to treat urinary tract infections and leprosy.

Glycodiazine is a sulfadiazine derivative with antihyperglycemic activity. Glycanamidine can lower blood sugar levels by increasing insulin release from pancreatic beta cells and increasing peripheral tissue sensitivity to insulin.